New Key Statistics Module, Z-Score and F-Score
ATH:CAIROMEZ Key Ratios
| Market Cap € M | 130.44 |
| Enterprise Value € M | 130.24 |
| P/E(ttm) | 1.06 |
| PE Ratio without NRI | 1.06 |
| Forward PE Ratio | -- |
| Price/Book | 0.73 |
| Price/Sales | 1.06 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) € M | 123.00 |
| EPS (TTM) € | 0.40 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.06 |
| EV-to-EBITDA | 1.06 |
| PEG | -- |
| Shares Outstanding M | 309.10 |
| Net Margin (%) | 99.76 |
| Operating Margin % | 99.76 |
| Pre-tax Margin (%) | 99.76 |
| Quick Ratio | 2.46 |
| Current Ratio | 2.46 |
| ROA % (ttm) | 103.90 |
| ROE % (ttm) | 104.10 |
| ROIC % (ttm) | 104.32 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
ATH:CAIROMEZ Number of Guru Trades
ATH:CAIROMEZ Volume of Guru Trades
Gurus Latest Trades with ATH:CAIROMEZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ATH:CAIROMEZ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers